Atlas Trials

A Pharmacokinetic Study of Modified Release (MR) Formulations of MIN-101 in Healthy Subjects

Clinical trial NCT03038646 · COMPLETED

Trial details

NCT number
NCT03038646
Sponsor
Minerva Neurosciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2016-11-30
Primary completion
2017-04-20
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.